…
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | - | -2.45M | -0.00M |
| Net income | - | -1.61M | -0.00M |
| Selling general administrative | - | 1.60M | - |
| Gross profit | - | -1.60M | - |
| Ebit | -19.54M | -2.17M | -0.01M |
| Ebitda | - | -1.60M | - |
| Non operating income net other | - | -0.57M | - |
| Operating income | - | -1.60M | -0.00M |
| Interest expense | 0.00M | 0.00M | 0.00M |
| Interest income | - | 1.16M | - |
| Net interest income | - | 1.16M | - |
| Income tax expense | 0.46M | - | - |
| Total revenue | - | 0.00M | - |
| Total operating expenses | - | 1.60M | - |
| Cost of revenue | - | 1.60M | - |
| Net income from continuing ops | - | -2.45M | - |
| Net income applicable to common shares | 83.30M | -1.61M | -0.01M |
| Breakdown | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 239.09M | 174.01M | 0.66M |
| Intangible assets | 113.68M | - | - |
| Other current assets | 2.38M | 0.05M | - |
| Total liab | 170.01M | 3.97M | 0.63M |
| Total stockholder equity | 69.08M | 5.00M | 0.02M |
| Deferred long term liab | 1.00M | - | 0.60M |
| Other current liab | 3.39M | - | 0.00M |
| Common stock | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 167.61M | 0.00M |
| Retained earnings | -1.78M | -1.61M | -0.00M |
| Other liab | 39.08M | 167.61M | - |
| Good will | 71.66M | - | - |
| Other assets | 1.05M | 173.66M | 0.60M |
| Cash | 7.24M | 0.31M | 0.02M |
| Total current liabilities | 130.93M | 0.40M | 0.63M |
| Net debt | 101.42M | 0.69M | 0.61M |
| Short term debt | - | - | 0.63M |
| Short long term debt | 108.66M | - | 0.63M |
| Other stockholder equity | - | 167.61M | - |
| Property plant equipment | 25.21M | - | - |
| Total current assets | 27.49M | 0.35M | 0.05M |
| Long term investments | - | 173.66M | - |
| Net tangible assets | -116.26M | 170.04M | 0.02M |
| Short term investments | 1.69M | - | - |
| Net receivables | 1.20M | - | - |
| Long term debt | - | 3.57M | - |
| Inventory | 12.51M | - | - |
| Accounts payable | 1.53M | 0.40M | - |
| Common stock total equity | - | 0.00M | - |
| Retained earnings total equity | - | -1.61M | - |
| Non currrent assets other | 1.05M | 173.66M | - |
| Non current assets total | 211.60M | 173.66M | 0.60M |
| Long term debt total | - | 3.57M | - |
| Breakdown | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|
| Type | yearly | yearly | yearly |
| Date | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | - | -172.50M | - |
| Change to liabilities | -25.00M | 0.40M | 0.00M |
| Total cashflows from investing activities | -1328.21M | -172.50M | -172.50M |
| Net borrowings | 1250.00M | 1.16M | 1.89M |
| Total cash from financing activities | -617.47M | 174.00M | 0.17M |
| Change to operating activities | -6.36M | 0.38M | -0.09M |
| Net income | 83.30M | -1.61M | -0.01M |
| Change in cash | -1993.39M | 0.28M | 0.07M |
| Begin period cash flow | 0.31M | 0.02M | - |
| End period cash flow | - | 0.31M | 0.02M |
| Total cash from operating activities | -47.71M | -1.21M | -0.09M |
| Issuance of capital stock | - | 172.35M | - |
| Depreciation | 16.67M | 16.67M | 16.67M |
| Other cashflows from investing activities | - | -172.50M | -172.50M |
| Change to inventory | 1.88M | 1.88M | 1.88M |
| Change to account receivables | 2.74M | 2.74M | 2.74M |
| Sale purchase of stock | - | 170.33M | 0.03M |
| Other cashflows from financing activities | -1867.48M | 2.50M | -1.80M |
| Change to netincome | -125.82M | 0.57M | 0.01M |
| Capital expenditures | 2.81M | 2.81M | 2.81M |
| Cash flows other operating | - | -0.58M | - |
| Cash and cash equivalents changes | - | 0.28M | - |
| Change in working capital | - | 0.38M | - |
| Other non cash items | - | -1.16M | - |
| Free cash flow | - | -1.21M | - |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| MKKGY Merck KGaA ADR |
-0.22 0.66% |
33.17 | 21.25 | 14.93 | 3.10 | 2.14 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
-2.76 1.62% |
167.12 | 24.86 | 15.11 | 3.13 | 1.98 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
-0.17 0.80% |
21.02 | - | 10.96 | 0.01 | 1.20 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
41.85 | - | 10.66 | 0.01 | 1.16 | 23.11 |
Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.
111 Broadway, Amityville, NY, United States, 11701
516 346 5270
91
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul Otto Wimer | Chief Operating Officer | 1965 |
| Mr. Daniel Patrick Harley | Exec. VP of Investor Relations & Director | 1965 |
| Mr. Timothy Bossidy | Interim Chief Exec. Officer | 1988 |
| Mr. Bernard Wang | Chief Financial Officer | 1968 |
| Mr. Daniel Patrick Harley | Executive VP of Investor Relations & Director | 1965 |
| Ms. Nicole Conboy | Chief Executive Officer | 1965 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.